The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Scaffold hopping
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Concepts and applications of molecular similarity
Johnson, M. A., & Maggiora, G. M. (1990) · Wiley eBooks · Cited by 1,301
“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening
Schneider, G., Neidhart, W., Giller, T., & Schmid, G. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991004)38:19<2894::aid-anie2894>3.0.co;2-f · Cited by 717
Erlanson, D. A., McDowell, R. S., & O'Brien, T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040031v · Cited by 642
Why do we need so many chemical similarity search methods?
Sheridan, R. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02411-x · Cited by 412
Pharmacophore Modeling and Three-dimensional Database Searching for Drug Design Using Catalyst
Kurogi, Y., & Guner, O. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372481 · Cited by 357
Feature trees: A new molecular similarity measure based on tree matching
Rarey, M., & Dixon, J. S. (1998) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008068904628 · Cited by 328
Böhm, H., & Klebe, G. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199625881 · Cited by 328
Self-citationKearsley, S. K., & Smith, G. M. (1990) · Tetrahedron Computer Methodology · doi:10.1016/0898-5529(90)90162-2 · Cited by 312
Ertl, P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0255782 · Cited by 292
CAVEAT: A program to facilitate the design of organic molecules
Lauri, G., & Bartlett, P. A. (1994) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124349 · Cited by 266
Computational methods for the structural alignment of molecules
Lemmen, C., & Lengauer, T. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008194019144 · Cited by 262
De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks
Schneider, G., Lee, M.-L., Stahl, M., & Schneider, P. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008184403558 · Cited by 251
Self-citationDopamine receptor agonists: selectivity and dopamine D1 receptor efficacy
Andersen, P. H., & Jansen, J. A. (1990) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(90)90194-3 · Cited by 234
Pierce, A. C., Rao, G., & Bemis, G. W. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030543u · Cited by 185
Novel technologies for virtual screening
Lengauer, T., Lemmen, C., Rarey, M., & Zimmermann, M. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)02939-3 · Cited by 168
The Most Common Chemical Replacements in Drug-Like Compounds
Sheridan, R. P. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0100806 · Cited by 168
Similarity searching in large combinatorial chemistry spaces
Rarey, M., & Ståhl, M. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1011144622059 · Cited by 157
Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
Langer, T., & Krovat, E. M. (2003) · PubMed · Cited by 86
Virtual Screening for Bioactive Molecules by Evolutionary De Novo Design
Schneider, G., Clément‐Chomienne, O., Hilfiger, L., Schneider, P., Kirsch, S. F., Böhm, H., & Neidhart, W. L. (2000) · Angewandte Chemie International Edition · Cited by 84
Self-citationMolecular recognition: the fragment approach in lead generation
Fattori, D. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)03007-1 · Cited by 82
Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design
Todorov, N., & Dean, P. M. (1997) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008042711516 · Cited by 81
A validation study on the practical use of automated de novo design
Ståhl, M., Todorov, N. P., James, T., Mauser, H., Boehm, H.-J., & Dean, P. M. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1021242018286 · Cited by 79
Compounds selective for dopamine receptor subtypes
Kebabian, J. W., Tarazi, F. I., Kula, N. S., & Baldessarini, R. J. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01075-1 · Cited by 72
Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors
Nærum, L., Nørskov‐Lauritsen, L., & Olesen, P. H. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00169-5 · Cited by 66
Scaffold Hopping in De Novo Design. Ligand Generation in the Absence of Receptor Information
Lloyd, D. G., Buenemann, C. L., Todorov, N. P., Manallack, D. T., & Dean, P. M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034222u · Cited by 63
Ligands for the Benzodiazepine Binding Site - a Survey
Teuber, L., Wätjen, F., & Jensen, L. H. (1999) · Current Pharmaceutical Design · doi:10.2174/138161280505230110100242 · Cited by 57
Three‐Dimensional Structure Database Searches
Good, A. C., & Mason, J. S. (1996) · Reviews in computational chemistry · doi:10.1002/9780470125847.ch2 · Cited by 51
De novo design and synthesis of HIV-1 integrase inhibitors
Makhija, M. T., Kasliwal, R. T., Kulkarni, V. M., & Neamati, N. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.02.005 · Cited by 49
de Esch, I. J. P., Mills, J. E. J., Perkins, T. D. J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001109k · Cited by 42
Drug prototypes and their exploitation
Timmerman, H. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90638-6 · Cited by 35
Structure-based design and protein X-ray analysis of a protein kinase inhibitor
Furet, P., Meyer, T., Strauss, A., Raccuglia, S., & Rondeau, J. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00715-6 · Cited by 33
Cited by
An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles
Baumann, M., & Baxendale, I. R. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.265 · Cited by 841
Rings in Clinical Trials and Drugs: Present and Future
Shearer, J., Castro, J. L., Lawson, A. D. G., MacCoss, M., & Taylor, R. D. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00473 · Cited by 479
Molecular photoswitches in aqueous environments
Volarić, J., Szymanski, W., Simeth, N. A., & Feringa, B. L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00547a · Cited by 438
Classification of scaffold-hopping approaches
Sun, H., Tawa, G., & Wallqvist, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.024 · Cited by 375
Ultrafast shape recognition to search compound databases for similar molecular shapes
Ballester, P. J., & Richards, W. G. (2007) · Journal of Computational Chemistry · doi:10.1002/jcc.20681 · Cited by 327
Metadata
- Authors
- Böhm, H.-J., Flohr, A., & Stahl, M.
- Venue
- Drug Discovery Today: Technologies
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 1
- Issue
- 3
- Pages
- 217-224
- ISSN
- 1740-6749 (ISSN-L)
- OpenAlex
- W4230274588
- Cited by
- 335
- References
- 31
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.